Market Cap

Scopus BioPharma Inc. Market Capitalization:

$16,833

USD as of Jan. 1, 2026

business Scopus BioPharma Inc. Company Profile

Scopus BioPharma Inc. Main Stock Listing

NASDAQ: SCPS

Market Capitalization History of Scopus BioPharma Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Scopus BioPharma Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $16,833 33.34%
Jan. 1, 2025 $12,624 -96.25%
Jan. 1, 2024 $336,666 -86.70%
Jan. 1, 2023 $2.5 M -90.27%
Jan. 1, 2022 $26.0 M -88.98%
Jan. 1, 2021 $235.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Scopus BioPharma Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Scopus BioPharma Inc. has the following listings and related stock indices.


Stock: NASDAQ: SCPS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.